OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector
At OCT and CTS China 2026, experts discussed how Chinese biotechs are becoming more central to the dealmaking environment.
At OCT and CTS China 2026, experts discussed how Chinese biotechs are becoming more central to the dealmaking environment.